Clinical Trials Logo

Clinical Trial Details — Status: Terminated

Administrative data

NCT number NCT01716650
Other study ID # 09-007710
Secondary ID
Status Terminated
Phase
First received
Last updated
Start date October 2012
Est. completion date September 2016

Study information

Verified date December 2017
Source Mayo Clinic
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

To assess the pain scores before and after saphenous nerve block placement in patients with degenerative joint disease of the ankle


Recruitment information / eligibility

Status Terminated
Enrollment 4
Est. completion date September 2016
Est. primary completion date September 2016
Accepts healthy volunteers No
Gender All
Age group 18 Years to 99 Years
Eligibility Inclusion Criteria:

- Patients evaluated with osteoarthritis who are surgical candidates for ankle fusion or total ankle replacement.

- Registered patients at Mayo Clinic in Florida with scheduled visit to see Dr.Whalen

Exclusion Criteria:

- Patients with lower extremity diabetic neuropathy

- History of prior trauma of ankle with residual nerve injury

- Current medication of pregabalin or gabalin

- Allergy to lidocaine.

Study Design


Related Conditions & MeSH terms


Locations

Country Name City State
United States Mayo Clinic Jacksonville Florida

Sponsors (1)

Lead Sponsor Collaborator
Mayo Clinic

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Ankle pain Patient's ankle pain will be assessed prior to and after the nerve block. The study will assess if pain score is lower after the saphenous nerve block 30 minutes

External Links